| Product Name |
Description |
Size |
Catalog Number |
Information |
Prices |
| Carboplatin |
cis-Diammine(1,1-cyclobutanedicarboxylato) platinum |
100 mg |
PK-CA577-1553-100 |
  |
 |
| Mifepristone |
11ß-(4-Dimethylamino)phenyl-17ß-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one, RU-486, RU-38486 |
50 mg |
PK-CA577-1561-50 |
 |
 |
| Actinomycin D |
Potent inducer of apoptosis in many cell lines |
50 mg |
PK-CA577-1036-50MG |
 |
 |
| Actinomycin D |
Potent inducer of apoptosis in many cell lines |
5 mg |
PK-CA577-1036-5MG |
 |
 |
| Actinomycin D (10 mM) |
Ready-to-use apoptosis inducer |
50 µl |
PK-CA577-1036-50 |
 |
 |
| Anisomycin |
Activator of p54 and MAP kinases; induces apoptosis e.g. in the human monoblastoid cell line |
10 mg |
PK-CA577-1549-10 |
 |
 |
| Apoptosis Inducer Set |
Contains 5 ready-to-use apoptosis inducers (Actinomycin D, Camptothecin, Cycloheximide, Dexamethasone, Etoposide) in a kit format |
1 kit |
PK-CA577-K121-5 |
 |
 |
| Betulinic acid |
Anti-tumor and anti-HIV agent that induces apoptosis |
25 mg |
PK-CA577-1552-25 |
 |
 |
| Brefeldin A |
Induces apoptosis via caspase activation |
5 mg |
PK-CA577-1560-5 |
 |
 |
| Camptothecin |
Induces apoptosis e.g. in Jurkat, osteosarcoma and hepatoma cells |
500 mg |
PK-CA577-1039-500MG |
 |
 |
| Camptothecin |
Induces apoptosis e.g. in Jurkat, osteosarcoma and hepatoma cells |
50 mg |
PK-CA577-1039-50MG |
 |
 |
| Camptothecin (2 mM) |
Ready-to-use apoptosis inducer |
1 ml |
PK-CA577-1039-1 |
 |
 |
| Colchicine |
Induce apoptosis e.g. in PC-12 cells and cerebellar granule cells |
1 g |
PK-CA577-1519 |
 |
 |
| Cycloheximide |
Induces apoptosis in a variety of cells but can also delay or inhibit apoptosis by other agents |
1 g |
PK-CA577-1041-1G |
 |
 |
| Cycloheximide (100 mM) |
Ready-to-use apoptosis inducer |
1 ml |
PK-CA577-1041-1 |
 |
 |
| Daunorubicin.HCl |
Induces DNA single strand breaks and apoptosis e.g. in HeLaS3 tumor cells |
10 mg |
PK-CA577-1524-10 |
 |
 |
| Dexamethasone |
Induces apoptosis e.g. in human thymocytes |
10 g |
PK-CA577-1042-10G |
 |
 |
| Dexamethasone |
Induces apoptosis e.g. in human thymocytes |
1 g |
PK-CA577-1042-1G |
 |
 |
| Dexamethasone (10 mM) |
Ready-to-use apoptosis inducer |
1 ml |
PK-CA577-1042-1 |
 |
 |
| Doxorubicin.HCl |
Anti-tumor antibiotic that induces apoptosis |
5 mg |
PK-CA577-1527-5 |
 |
 |
| Etoposide |
Induces apoptosis e.g. in human T cells, mouse thymocytes, and HL-60 human leukemia cells |
250 mg |
PK-CA577-1043-250MG |
 |
 |
| Etoposide |
Induces apoptosis e.g. in human T cells, mouse thymocytes, and HL-60 human leukemia cells |
25 mg |
PK-CA577-1043-25MG |
 |
 |
| Etoposide (10 mM) |
Ready-to-use apoptosis inducer |
100 µl |
PK-CA577-1043-100 |
 |
 |
| Genistein |
Produces cell cycle arrest and apoptosis (>99% pure) |
10 mg |
PK-CA577-1533-10 |
 |
 |
| Genistein |
Produces cell cycle arrest and apoptosis (>99% pure) |
100 mg |
PK-CA577-1533-100 |
 |
 |
| Ionomycin (Calcium salt) |
|
5 mg |
PK-CA577-1566-5 |
 |
 |
| Ionomycin (free acid) |
|
5 mg |
PK-CA577-1565-5 |
 |
 |
| Mitomycin C |
Inhibitor of DNA synthesis, nuclear division. Induces apoptosis in cancer cells. |
10 mg |
PK-CA578-M1108-10 |
 |
 |
| Mitomycin C |
Inhibitor of DNA synthesis, nuclear division. Induces apoptosis in cancer cells. |
100 mg |
PK-CA578-M1108-100 |
 |
 |
| Mitomycin C |
Inhibitor of DNA synthesis, nuclear division. Induces apoptosis in cancer cells. |
5 mg |
PK-CA578-M1108-5 |
 |
 |
| Okadaic acid |
Induces apoptosis e.g. in human breast carcinoma cells (MB-231 and MCF-7) and in myeloid cells, but inhibits glucocorticoid-induced apoptosis in T-cell hybridomas |
25 µg |
PK-CA577-1543-25 |
 |
 |
| Phorbol-12-myristate 13-acetate (PMA) |
Inhibits apoptosis induced by the Fas antigen, but induces apoptosis e.g. in HL-60 promyelocytic leukemia cells |
5 mg |
PK-CA577-1544-5 |
 |
 |
| Rapamycin |
Reported to induce apoptosis in a murine B cell line (>99% pure) |
5 mg |
PK-CA577-1568-5 |
 |
 |
| Rapamycin |
Reported to induce apoptosis in a murine B cell line (>99% pure) |
50 mg |
PK-CA577-1568-50 |
 |
 |
| Rosiglitazone |
Induces apoptosis in various cells, e.g. in vascular smooth muscle cells |
100 mg |
PK-CA577-1559-100 |
 |
 |
| Rosiglitazone |
Induces apoptosis in various cells, e.g. in vascular smooth muscle cells |
5 mg |
PK-CA577-1559-5 |
 |
 |
| Staurosporine |
Potent apoptosis inducer |
100 µg |
PK-CA577-1048-010 |
  |
 |
| Staurosporine |
Potent apoptosis inducer |
1 mg |
PK-CA577-1048-1 |
  |
 |
| Tamoxifen citrate |
Induces apoptosis e.g. in human malignant glioma cell lines |
1 g |
PK-CA577-1551 |
 |
 |
| Thapsigargin |
Induces apoptosis in rat thymocytes and in human hepatoma cells (>99% pure) |
1 mg |
PK-CA577-1558-1 |
 |
 |
| Tyrphostin AG 1295 |
Specific and potent inhibitor of JAK2 protein tyrosine kinase, EGF receptor autophosphorylation, DNA synthesis and cell growth (>99%)
|
5 mg |
PK-CA577-1571-5 |
 |
 |
| Tyrphostin AG 490 |
Specific and potent inhibitor of JAK2 protein tyrosine kinase, EGF receptor autophosphorylation, DNA synthesis and cell growth (>99%)
|
5 mg |
PK-CA577-1570-5 |
 |
 |